BRPI1001317A8 - Artigo moldado secado por congelamento contendo fosfato de ascorbila de magnésio - Google Patents

Artigo moldado secado por congelamento contendo fosfato de ascorbila de magnésio

Info

Publication number
BRPI1001317A8
BRPI1001317A8 BRPI1001317A BRPI1001317A BRPI1001317A8 BR PI1001317 A8 BRPI1001317 A8 BR PI1001317A8 BR PI1001317 A BRPI1001317 A BR PI1001317A BR PI1001317 A BRPI1001317 A BR PI1001317A BR PI1001317 A8 BRPI1001317 A8 BR PI1001317A8
Authority
BR
Brazil
Prior art keywords
dried molded
freeze
ascorbyl phosphate
magnesium ascorbyl
molded article
Prior art date
Application number
BRPI1001317A
Other languages
English (en)
Inventor
Malessa Ralf
Original Assignee
Dr Suwelack Skin & Health Care Ag
Medskin Solutions Dr Suwelack Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Suwelack Skin & Health Care Ag, Medskin Solutions Dr Suwelack Ag filed Critical Dr Suwelack Skin & Health Care Ag
Publication of BRPI1001317A2 publication Critical patent/BRPI1001317A2/pt
Publication of BRPI1001317A8 publication Critical patent/BRPI1001317A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ARTIGO MOLDADO SECADO POR CONGELAMENTO CONTENDO FOSFATO DE ASCORBILA DE MAGNÉSIO. A presente invenção refere-se aos artigos moldados liofilizado contendo alginato e fosfato de ascorbila de magnésio, bem como opcionalmente uma ou mais substâncias ativas e/ou substâncias auxiliares. Além disso, a invenção refere-se a métodos para fabricar estes artigos moldados liofilizados, a combinação de tais artigos moldados liofilizados em disposições de kit-de-partes juntamente com soluções aquosas, bem como o uso dos artigos moldados liofilizados e das combinações de kit-de-partes para aplicação farmacêutica e cosmética.
BRPI1001317A 2009-04-22 2010-04-20 Artigo moldado secado por congelamento contendo fosfato de ascorbila de magnésio BRPI1001317A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09158475 2009-04-22

Publications (2)

Publication Number Publication Date
BRPI1001317A2 BRPI1001317A2 (pt) 2011-06-21
BRPI1001317A8 true BRPI1001317A8 (pt) 2016-09-13

Family

ID=41130369

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1001317A BRPI1001317A8 (pt) 2009-04-22 2010-04-20 Artigo moldado secado por congelamento contendo fosfato de ascorbila de magnésio

Country Status (6)

Country Link
US (1) US9125825B2 (pt)
EP (1) EP2243469B1 (pt)
JP (1) JP5676134B2 (pt)
CN (1) CN101919805B (pt)
BR (1) BRPI1001317A8 (pt)
ES (1) ES2386616T3 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395469A (zh) * 2009-04-22 2016-03-16 苏维拉克博士皮肤治疗方案股份公司 活性物质的冻干组合物
CN104080434B (zh) * 2012-02-10 2017-11-07 宝洁公司 用于展现化妆品组合物的美白有益效果的套盒和方法
DE102013018573A1 (de) 2013-10-31 2015-05-21 Stephan Teichmann Oxidationsstabile Zubereitung
CN104473778A (zh) * 2014-12-01 2015-04-01 湖州凯普秀生物科技有限公司 一种定量球形体系及其制备方法
EP3329897A4 (en) * 2015-07-28 2019-07-24 Ling Dong AUXILIARY PREPARATION IN ANY FORM OF FREEZED DRYING AND METHOD OF MANUFACTURING THEREOF
CN105833338A (zh) * 2016-04-25 2016-08-10 天津市赛宁生物工程技术有限公司 可用于医用组织粘合剂的有机镁盐复合物
CN109364082A (zh) * 2018-06-08 2019-02-22 河北爱尔海泰制药有限公司 一种高稳定性注射用复方维生素冻干制剂组合物
CN112203630A (zh) * 2018-07-03 2021-01-08 荷兰联合利华有限公司 冷冻干燥的化妆品组合物
CN111904871B (zh) * 2019-04-22 2022-05-17 上海震春生物科技有限公司 粉体的制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
IE53696B1 (en) 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
JPH02215707A (ja) 1989-02-15 1990-08-28 Chisso Corp 皮膚化粧料
JPH02231496A (ja) 1989-03-06 1990-09-13 Chisso Corp 水易溶性リン酸―ｌ―アスコルビルマグネシウム、その製造法及び化粧料
DE4028622C2 (de) 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen
JPH05208983A (ja) * 1991-02-21 1993-08-20 Chisso Corp 水易溶性リン酸−ｌ−アスコルビルマグネシウムの製造方法及びそれを用いた化粧料
DE4201179A1 (de) 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE4328329C2 (de) 1992-08-26 1998-02-12 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
US5843347A (en) 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
ATE260646T1 (de) 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
US6458379B1 (en) 1999-10-15 2002-10-01 Nitto Denko Corporation Sheet for whitening cosmetics and method for using the same
US6497887B1 (en) * 2000-04-13 2002-12-24 Color Access, Inc. Membrane delivery system
JP2001340375A (ja) * 2000-05-31 2001-12-11 Toyobo Co Ltd 創傷被覆材
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
FR2845002B1 (fr) * 2002-09-30 2004-11-05 Oreal Composition cosmetique ou dermatologique contenant un derive d'acide ascorbique et un filtre
DE10248314A1 (de) 2002-10-16 2004-04-29 Dr. Suwelack Skin & Health Care Ag Verwendung von Formkörpern zur äußeren Anwendung
JP2006504799A (ja) 2002-10-16 2006-02-09 ドクトル ズベラック スキン ウント ヘルス ケア アクチェンゲゼルシャフト 形成物の身体表面への利用法
JP4377123B2 (ja) 2002-10-31 2009-12-02 日興製薬株式会社 皮膚外用剤組成物
DE10350654A1 (de) 2003-10-29 2005-06-02 Dr. Suwelack Skin & Health Care Ag Collagen-Träger-Wirkstoff-Zusammensetzung
BRPI0507113A (pt) 2004-01-28 2007-06-19 Unilever Nv corpos porosos, método para preparar corpos porosos, e, soluções ou dispersões
FR2886845B1 (fr) 2005-06-13 2009-07-03 Oreal Produit cosmetique solide
DE102006038629A1 (de) 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Stabilisierte Wirkstoffzusammensetzung
WO2009014347A2 (en) 2007-07-20 2009-01-29 G1 Biztech Co., Ltd Stabilized antioxidant-containing particles, process for preparing the same, and composition comprising the same

Also Published As

Publication number Publication date
CN101919805B (zh) 2014-01-29
US9125825B2 (en) 2015-09-08
ES2386616T3 (es) 2012-08-23
JP5676134B2 (ja) 2015-02-25
EP2243469B1 (de) 2012-06-27
BRPI1001317A2 (pt) 2011-06-21
US20100272834A1 (en) 2010-10-28
HK1149509A1 (en) 2011-10-07
JP2010254689A (ja) 2010-11-11
EP2243469A1 (de) 2010-10-27
CN101919805A (zh) 2010-12-22

Similar Documents

Publication Publication Date Title
BRPI1001317A8 (pt) Artigo moldado secado por congelamento contendo fosfato de ascorbila de magnésio
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
TR201911258T4 (tr) 3D in vitro çift fazlı kıkırdak-kemik yapısı.
BR112012006635A2 (pt) partículas de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas carregadas de agente ativo e métodos de fazer e usar as mesmas
BRPI0914684C1 (pt) uso de hsp70 ou um fragmento funcional ou variante do mesmo, e, hsp70 ou um fragmento funcional ou variante do mesmo
BRPI1102843B8 (pt) Composições de limpeza límpidas, de baixa irritação com ph relativamente baixo
JOP20130273B1 (ar) مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
BR112014031874A2 (pt) método para preparar células-tronco em concentração elevada
BR112015015898A8 (pt) composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
BR112012013664A2 (pt) rabdovírus oncolítico
AU323704S (en) Medical instrument
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
MX2019000547A (es) Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas.
BR112015006426A2 (pt) composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos
BR102013022698B8 (pt) Éster de poliglicerol, processo para a produção do mesmo, seu uso e formulação cosmética ou farmacêutica
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112015015864A2 (pt) composição farmacêutica, método de preparação de uma composição farmacêutica, método de tratamento de um indivíduo com uma condição de dor severa, e, uso de uma composição farmacêutica
BRPI0922653B8 (pt) uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
BR112012004009A2 (pt) substâncias carbonáceas de alta potência
BR112015013071A2 (pt) solução de trombina e seus métodos de uso
BR112013020359A2 (pt) colágeno gelificável e meios para a sua provisão
TR201902755T4 (tr) Depolama kararliliğina sahi̇p li̇yofi̇li̇ze tri̇pepti̇t formülasyonlari.

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MEDSKIN SOLUTIONS DR. SUWELACK AG (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]